As 2026 begins, Java Burn reviews are once again climbing search results, not because of hype alone, but because ...
A woman and child were killed in a crash Friday, March 27, according to Virginia State Police.
At Dr. David Macklin's weight management practice in Toronto, the name Ozempic is mentioned almost daily in appointments. But recently, another word is coming up just as often — generics. "It is a ...
Eren Koç Developer & Designer [email protected] Eren Önder Developer & Designer [email protected] Ramazan Giyici Developer & Designer [email protected] A comprehensive ...
New Delhi: In a significant development in an ongoing pharmaceutical dispute, the Supreme Court of India has declined to interfere with an order of the Allahabad High Court in a case involving Jamp ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...
Following the March 20, 2026 patent expiry of semaglutide, India is witnessing a rapid influx of generic GLP-1 receptor agonists. This shift is reshaping market dynamics, with evolving regulatory ...
India's semaglutide market has entered a new phase of competition, with prices falling steeply after more than 15 generic versions of the drug were introduced within just two days of patent expiry.
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...
Novo Nordisk lost its patent over semaglutide, which makes Wegovy and Ozempic, in India. That means the floodgates of generics opened and overnight the price of weight-loss drugs dropped by 80%. There ...
Dr Reddy’s Laboratories has launched India’s first generic semaglutide injection for Type 2 diabetes, following patent expiry of the original drug. Priced at about ₹4,200 per month, it offers a more ...
In a shot in the arm for India’s high-growth weight-loss medicines market, generic versions of Danish drugmaker Novo Nordisk’s blockbuster drug semaglutide will hit the shelves on Saturday, with price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results